Protara Therapeutics, Inc.

Nasdaq:TARA

Biological Products, (No Diagnostic Substances)·NEW YORK, NY

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/10/26	→
10-Q	Q3 2025	9/30/25	11/10/25	→
10-Q	Q2 2025	6/30/25	8/11/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	3/5/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
↓

Earnings Releases (8-K)

22 shown

Filed	Period
3/10/26	Q1 FY2026	→
11/10/25	Q4 FY2025	→
8/11/25	Q3 FY2025	→
5/8/25	Q2 FY2025	→
3/5/25	Q1 FY2025	→
11/12/24	Q4 FY2024	→
↓

News (8-K)

58 shown

Filed	Type	Description
2/24/26	Reg FD	Regulation FD Disclosure	→
12/15/25	Other	Other Events	→
12/8/25	Agreement	Entry into a Material Definitive Agreement	→
12/3/25	Reg FD	Regulation FD Disclosure	→
11/19/25	Reg FD	Regulation FD Disclosure	→
6/12/25	Vote	Submission of Matters to a Vote of Security Holders	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
3/6/26	424B7	PROSPECTUS SUPPLEMENT	→
2/2/26	424B7	PROSPECTUS SUPPLEMENT	→
12/9/25	424B7	PROSPECTUS SUPPLEMENT	→
12/5/25	424B5	PROSPECTUS SUPPLEMENT	→
12/4/25	424B5	PROSPECTUS SUPPLEMENT	→
8/11/25	S-8	REGISTRATION STATEMENT	→
↓

Filing History(772 filings)

TypeDateAccessionPeriodSize

10-K

Mar 10, 2026

0001213900-26-025433ANNUAL REPORT

Dec 31, 2025

8.1 MB

8-K

Mar 10, 2026

0001213900-26-025432CURRENT REPORT

Mar 10, 2026

281.6 KB

144

Mar 6, 2026

0001104659-26-024805

—

6.9 KB

144

Mar 6, 2026

0001104659-26-024803

—

7.1 KB

424B7

Mar 6, 2026

0001213900-26-024668PROSPECTUS SUPPLEMENT

—

25.0 KB

144

Mar 4, 2026

0001104659-26-023665

—

6.3 KB

144

Mar 4, 2026

0001104659-26-023663

—

6.5 KB

SCHEDULE 13G

Mar 2, 2026

0001104659-26-022274

—

15.2 KB

144

Feb 25, 2026

0001104659-26-019854

—

6.3 KB

144

Feb 25, 2026

0001104659-26-019853

—

6.5 KB

144

Feb 24, 2026

0001104659-26-019328

—

5.2 KB

144

Feb 24, 2026

0001104659-26-019326

—

5.3 KB

8-K

Feb 24, 2026

0001213900-26-019617CURRENT REPORT

Feb 23, 2026

28.0 MB

SCHEDULE 13G/A

Feb 17, 2026

0001274173-26-000085

—

12.3 KB

424B7

Feb 2, 2026

0001213900-26-010806PROSPECTUS SUPPLEMENT

—

30.3 KB

Jan 27, 2026

0001213900-26-008222PRIMARY DOCUMENT

Jan 26, 2026

5.0 KB

Jan 27, 2026

0001213900-26-008221PRIMARY DOCUMENT

Jan 26, 2026

5.0 KB

Jan 27, 2026

0001213900-26-008224PRIMARY DOCUMENT

Jan 26, 2026

5.0 KB

Jan 27, 2026

0001213900-26-008223PRIMARY DOCUMENT

Jan 26, 2026

5.0 KB

Jan 22, 2026

0001213900-26-006711PRIMARY DOCUMENT

Jan 20, 2026

5.0 KB

Jan 22, 2026

0001213900-26-006709PRIMARY DOCUMENT

Jan 20, 2026

5.0 KB

Jan 22, 2026

0001213900-26-006708PRIMARY DOCUMENT

Jan 20, 2026

5.1 KB

Jan 22, 2026

0001213900-26-006707PRIMARY DOCUMENT

Jan 20, 2026

5.0 KB

Jan 21, 2026

0001213900-26-006231PRIMARY DOCUMENT

Jan 16, 2026

7.6 KB

Jan 21, 2026

0001213900-26-006230PRIMARY DOCUMENT

Jan 16, 2026

7.5 KB

25 filings shown

Filed	Form	Description
4/25/25	DEFA14A	ADDITIONAL MATERIALS	→
4/25/25	DEF 14A	DEF 14A	→
4/26/24	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
4/26/24	DEF 14A	DEF 14A	→
4/26/23	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
4/26/23	DEF 14A	DEF 14A	→
↓

Protara Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(772 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
1/27/26	4	PRIMARY DOCUMENT	→
1/27/26	4	PRIMARY DOCUMENT	→
1/27/26	4	PRIMARY DOCUMENT	→
1/27/26	4	PRIMARY DOCUMENT	→
1/22/26	4	PRIMARY DOCUMENT	→
1/22/26	4	PRIMARY DOCUMENT	→
↓

Filed	Form	Description
3/6/26	144	144	→
3/6/26	144	144	→
3/4/26	144	144	→
3/4/26	144	144	→
3/2/26	SCHEDULE 13G	SCHEDULE 13G	→
2/25/26	144	144	→
↓